source
- Cue Biopharma names Shao‑Lee Lin CEO and licenses new allergy asset from Taiwan and ChinaCue Biopharma announced a reboot, bringing in biotech veteran Shao‑Lee Lin as its new chief executive. Lin, founder of Acelyrin, will lead the Boston‑based company as it expands its pipeline. The…
- Amgen files label update for Tavneos as FDA intensifies withdrawal pushAmgen has submitted a supplemental filing to the FDA to revise the prescribing information for its osteoporosis drug Tavneos. The amendment adds expanded safety warnings as the agency escalates it…